Corona Remedies IPO
Historical offer record. This offer is closed for applications. Prices and subscriptions describe the past offer; GMP observations are unofficial past records, not current quotes or listing predictions.
Data provider: FinAPI. This is a third-party summary, not an official prospectus. Read our data limitations and editorial policy.
No GMP observations are available for this historical offer record. No premium or listing-gain estimate is shown.
Price band
₹1008 – ₹1062
Lot size
14 shares
Offer application amount
₹14,868
Issue size
₹655.37 Cr
Historical offer amount for 1 lot at the upper issue price. Confirm the lot size and application terms in the issuer prospectus.
Reported IPO schedule
| Open date | 8 Dec 2025 |
| Close date | 10 Dec 2025 |
| Allotment finalisation | 11 Dec 2025 |
| Refund initiation | 12 Dec 2025 |
| Shares credited to demat | 12 Dec 2025 |
| Reported listing date | 15 Dec 2025 |
About Corona Remedies
Founded in August 2004, Corona Remedies Limited is one of the leading pharmaceutical companies that is involved in manufacturing and selling products for women’s health, heart care, pain relief, urology, and other treatments. As per the report, among 30 others, Corona Remedies is the 2nd largest company in the Indian Pharmaceutical Market (“IPM”). Moreover, the company comprises a total of 88 R&D employees as of December 31, 2024.
Company summary supplied by FinAPI. Read the prospectus for the issuer's disclosures and audited financials.
Offer documents and primary references
Read the issuer's offer document and any corrigenda for the full disclosures. A third-party details page is a summary; SEBI filing access does not imply an endorsement of the offer or this website.
IPO information is sourced from public feeds and shown for general information only. It is not a recommendation to apply for this or any IPO. IPOs are equity investments and carry market risk; listing gains are not guaranteed and SME IPOs are especially volatile. Grey Market Premium (GMP) is unofficial and not endorsed by SEBI or the exchanges. Equity IPOs are applied for through a demat and trading account, not through mutual fund distribution services. Read the RHP and consult a SEBI-registered investment adviser before investing.